http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-62637-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate | 1996-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e639ecdd3afaf544027b0451d3d041e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e264106350087d62c4a6c5f7df96c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51a79e8cd4371d0cec39181c3c0cb11c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5edd74be7053f935d3f6f1fb452744cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0cbfa55ced3e0f4d5e57ddc4275ebe |
| publicationDate | 2000-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-62637-B1 |
| titleOfInvention | PHARMACEUTICAL FORM FOR EXTERNAL APPLICATION AND METHOD OF RECOVERY |
| abstract | The medicamentous form includes Galantamin or its pharmaceutically acceptable salt as active substance in a suitable ointment base of hydrogenous type. The method for the preparation of the medicamentous form guarantees its stability. The gel can be diluted in water for reducing the concentration of the active component where it preserves its consistence. It is used for local, dosage and control stimulation of the acetylcholinomediated transmission of the nervous impulse by individual penetration in the skin or the mucous membranes or by the application of physiotherapuetical methods. 6 claims |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-1055-U1 |
| priorityDate | 1996-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.